STAGE IIIA2 OVARIAN CANCER AJCC V8
Clinical trials for STAGE IIIA2 OVARIAN CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA2 OVARIAN CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIA2 OVARIAN CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise in shrinking ovarian tumors before surgery
Disease control OngoingThis early-phase trial is testing the drug olaparib in 15 people with newly diagnosed BRCA-mutant ovarian, fallopian tube, or peritoneal cancer. Participants take olaparib for two cycles before their planned surgery to see if it can shrink tumors and is safe. The goal is to find …
Matched conditions: STAGE IIIA2 OVARIAN CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:25 UTC
-
Scientists build model to predict chemo nerve damage
Knowledge-focused OngoingThis study looks at over 1,300 cancer patients to find out who is more likely to develop nerve damage (tingling or numbness in hands and feet) from taxane chemotherapy. Researchers will track factors like age, gender, and pre-existing conditions to create a prediction tool. The g…
Matched conditions: STAGE IIIA2 OVARIAN CANCER AJCC V8
Sponsor: SWOG Cancer Research Network • Aim: Knowledge-focused
Last updated May 26, 2026 05:40 UTC